Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fecal microbiota transplantation (FMT) developed by the Army Medical University is an investigational live biotherapeutic product formulated into oral capsules. It is being studied for the treatment of chronic insomnia in a randomized, placebo-controlled clinical trial. The therapy aims to improve sleep by modulating the patient's gut microbiome. The underlying hypothesis is that altering the gut microbiota composition can influence peripheral inflammatory factors, neurotransmitters, and sex hormones, which in turn affects sleep status.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fecal microbiota transplant (Army Medical University).